Lotus Pharm vs Taigen Biopharmaceuticals Holdings: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Taigen Biopharmaceuticals Holdings (4157) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Taigen Biopharmaceuticals Holdings

0%+6483%-56%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYTaigen Biopharmaceuticals HoldingsYoY
Oct 2026NT$2.13 billion-22.5%NT$5.2 million+60.2%
Sep 2026NT$2.77 billion+128.0%NT$3.2 million+212.8%
Aug 2026NT$2.11 billion+81.7%NT$7.1 million+172.2%
Jul 2026NT$2.49 billion+3.9%NT$3 million-4.0%
Jun 2026NT$3.4 billion+225.5%NT$3 million-7.1%
May 2026NT$2.32 billion+105.8%NT$2.9 million-22.7%
Apr 2026NT$3.09 billion+19.9%NT$2.3 million-37.8%
Mar 2026NT$4.35 billion+173.6%NT$1.4 million-55.9%
Feb 2026NT$2.24 billion+131.5%NT$2.9 million-15.5%
Jan 2026NT$2.05 billion-5.5%NT$6 million+43.0%
Dec 2025NT$2.44 billion+66.9%NT$223.8 million+6,482.8%
Nov 2025NT$1.06 billion-0.2%NT$4.1 million+30.8%
Oct 2025NT$2.75 billion+46.0%NT$3.3 million-16.7%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16